House Scorecards logoHouse Scorecards

Home / Scorecards / HUM

HUM Dividend Scorecard

Humana Inc. · Stock — Healthcare · graded on the House framework — is the payout covered, is the yield real or a trap, and does it compound or just pay? Snapshot · Week of October 19, 2026

HUMHumana Inc.Stock — Healthcare
Yield
0.84%
$0.885/qtr at $422.07
Dividend
$0.885/qtr
Unchanged since Dec. 2022
Payout ratio
33.4%
Of trailing earnings
Pays
Quarterly
House verdict

Covered, but thin and flat. A 0.84% yield on a 33.4% trailing payout is safe but small: $0.885 a quarter, unchanged since December 2022. The payout is well covered by current earnings, but for an income card the dividend is neither large nor growing — nearly four years without a raise.

Key risk: Medicare Advantage economics — the payout is safe at 33.4%, but a margin squeeze in its core senior plans is what would test a dividend that has not grown since 2022.

Changes if: Trailing payout rises sharply, or the flat rate extends while earnings fall.

What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.

HUM in the House

Room: Consumer Reliability. Not one of the House's current holdings — in Order a New House it takes a seat in this room and carries the room's 19% target. Target 19% — the House's biggest room. Broad, quality-screened dividend payers: the reliable base the income is built on.

More cards in the Consumer Reliability room

Keep going

Every card is graded the same way and re-checked against the company's own filings. The Weekly House Score reports whatever crosses a House threshold; the House Tracker is the spreadsheet the framework itself runs on.

Don't see the name you want? Request a Card — we build it from the company's filings and add it to the library. Or Order a New House and see this card's room and target weight in a full plan.

Figures are the snapshot from the week of October 19, 2026, checked against the company's SEC filings (EDGAR) and announcements — not a live feed, and not financial advice. Read the full disclaimers.